Search results
Gateway - Quartz
Quartz· 14 hours agoMedicare will start covering the popular weight loss drug Wegovy for patients who are prescribed the medication as a way to reduce their risk of serious ...
Here are four reasons Medicare drug-price "negotiation" in NJ isn't truly a negotiation.
Gannett via AOL· 6 days agoFour reasons Medicare drug-price "negotiation" isn't truly a negotiation. For 2024, New Jersey...
Why Blue Cross of Michigan is axing coverage of popular weight loss drugs
Detroit News· 7 days agoBlue Cross Blue Shield of Michigan is dropping coverage of popular weight loss drugs, citing...
Here are four reasons Medicare drug-price 'negotiation' in NJ isn't truly a negotiation.
App.com | Asbury Park Press via Yahoo News· 6 days agodrug benefit. Dubbing it a negotiation only obscures the reality of a process in which the...
$2,000 Cap On Out-Of-Pocket Drug Costs To Help Millions Of Medicare Beneficiaries
Forbes· 6 days agoThe Inflation Reduction Act’s cap of $2,000 on annual out-of-pocket spending on outpatient drugs...
Lost chances to treat overdose survivors are documented in new Medicare study
WFLA Tampa Bay· 2 days agoA new study documents lost opportunities to treat drug overdose survivors covered by the Medicare program — and illustrates the difficulty of managing chronic pain. Overdose survivors “should be at…
Amazon Pharmacy Targets Medicare Population
Forbes· 1 day agoMillions of seniors who are 65 and older tend to have drug coverage if they purchase privatized health insurance known as Medicare Advantage or a...
Amazon's RxPass Extends to Medicare Recipients: How to Use the Online Pharmacy Perk
CNET· 10 hours agoPeople who receive Medicare can now use RxPass, Amazon Pharmacy's subscription service that for an...
Weight Loss Drugs and Medicare: What You Need to Know
TheStreet.com· 6 days agoMore weight loss drugs have been approved for coverage by Medicare, but what are the challenges potential users face? Medicare has recently approved coverage of GLP-1 drugs such as Wegovy to address hypertension.
US Drug Negotiations Plan Shifts Focus for Rare Disease Programs
Bloomberg Law· 2 days agoThe rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development ...
